Author name: Leonardo Arias

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it harder to invest in companies advancing the technology.

The settlement brings to a close litigation from pension funds that argued Cencora’s leadership ignored red flags about improper opioid distribution practices for years in order to profit.

  Shutterstock   Contar con una línea de crédito es una de las opciones más versátiles para quienes buscan apoyo financiero inmediato sin necesidad de tramitar un nuevo crédito cada vez. Esta herramienta se ha convertido en una alternativa ági …

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting new technologies to treat heart conditions.

Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip insurance. This is not the first time Novo has partnered with a pharmacy to offer the blockbuster drugs.

Waltham, Massachusetts–based Skyhawk Therapeuticshas been collecting collaborations with larger companies in spades since launching in 2018.

Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal neuralgia and type 1 diabetes.

Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain episodes in patients with sickle cell disease over the 48-week treatment period.

The telehealth firm is targeting international expansion as part of its strategic revamp.

The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according to analysts at BMO Capital Markets.